Lantern Pharma Inc. (NASDAQ: LTRN), a clinical-stage, AI-driven precision oncology company, today announced the launch of ZetaOmics, the computational-biology module of its multi-agentic AI ...
Today, the integration of AI and digital technologies is fundamentally rewriting the rules of R&D—serving as the ultimate breakthrough to shatter industry bottlenecks and drive unprecedented ...
Illumina dominates genomics sequencing with recurring growth, NovaSeq X catalysts, and improving margins/FCF. Click to know ...
U.S. Optical Genome Mapping Market is projected to reach USD 828.09 Million by 2035, while Europe is expected to reach USD ...
The infrastructure moment for AI-driven drug discovery continues to accelerate, with billion-dollar investments flowing into ...
As instruments grow faster, leaders say clinical impact will depend on trust, standards, data, and assays built for real ...
The First Agentic Operating System for Life Sciences R&DPRESS RELEASE Already running NVIDIA BioNeMo in production, the SigmaticOS now ...
Natera delivers robust revenue growth, raising 2026 guidance to $2.74–$2.82 billion, but remains unprofitable. Read more on ...
The growing role of artificial intelligence (AI) is transforming the way people do business. On this month’s "Washtenaw ...
General purpose AI tools for science, such as Claude Science, promise to accelerate research. But which is right for you?
Some results have been hidden because they may be inaccessible to you
Show inaccessible results